Pages that link to "Q70397454"

The following pages link to Influence of sex and oral contraceptive steroids on antipyrine metabolite formation (Q70397454):

Displaying 28 items.

• Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis (Q34346052) (← links)
• The disposition of antipyrine and its metabolites in young and elderly healthy volunteers (Q34416893) (← links)
• Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach (Q34418061) (← links)
• Antipyrine clearance and metabolism in patients with psoriasis (Q34448073) (← links)
• Effects of tobacco smoking and oral contraceptive use on theophylline disposition (Q34513078) (← links)
• Influence of sex and oral contraceptive steroids on paracetamol metabolism (Q34513321) (← links)
• Alterations in prednisolone disposition as a result of time of administration, gender and dose (Q34621156) (← links)
• Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis (Q34621602) (← links)
• Accuracy and clinical utility of simplified tests of antipyrine metabolism (Q34621803) (← links)
• Verapamil disposition--effects of sulphinpyrazone and cimetidine (Q34622354) (← links)
• Influence of age, sex, pregnancy and protein-calorie malnutrition on the pharmacokinetics of salicylate in rats (Q36004410) (← links)
• Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives (Q38522099) (← links)
• Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo Approach (Q39548977) (← links)
• Antipyrine as a model drug to study hepatic drug-metabolizing capacity (Q39652034) (← links)
• Sex-Related Differences in Drug Disposition in Man (Q40179654) (← links)
• Oral contraceptives. Are drug interactions of clinical significance? (Q40832390) (← links)
• Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis (Q42040905) (← links)
• Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives (Q49323100) (← links)
• Effects of age, sex and breed on antipyrine disposition in calves (Q50897339) (← links)
• Determination of theophylline clearance in South African children (Q51050930) (← links)
• Sex-related differences in theophylline pharmacokinetics (Q69393487) (← links)
• Salivary antipyrine half-life during injectable progestagen contraception (Q70028173) (← links)
• The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women (Q70490332) (← links)
• Antipyrine clearance in patients with Gilbert's syndrome (Q70710448) (← links)
• Influence of alaproclate on antipyrine metabolite formation in man (Q70733898) (← links)
• Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids (Q71390597) (← links)
• 13CAminopyrine breath test detects altered liver metabolism caused by low-dose oral contraceptives (Q71811844) (← links)
• Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism (Q72281596) (← links)